We’ve been there. We understand.
We have cloned, sequenced, synthesized, pipetted, assayed, analyzed and published. We have worked on cross-functional teams, launched products, led departments, negotiated deals and managed alliances.
We bring the expertise of a large pharmaceutical or biotech company to our clients, including first-hand knowledge of the intricacies inherent in drug development and business transactions.
Suzy Jones founded DNA Ink with more than 30 years of biotech experience. Most recently she headed the Business Development group at Genentech.
Deidre Roniger has more than 25 years of biotech experience in commercial strategy and analytics. She has led large departments, launched products, and guided investment decisions for large biotech.
Curtis Hecht has executive level experience with pharmaceutical companies of all sizes and has over 30 years of drug development experience
